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Prevalence of impaired glucose tolerance
and other types of dysglycaemia among
young twins and singletons in Guinea-
Bissau
Ditte Egegaard Hennild1,2*, Morten Bjerregaard-Andersen1,3,4, Luis Carlos Joaquím1,5ˆ, Kaare Christensen6,7,8,
Morten Sodemann1,2, Henning Beck-Nielsen3,9 and Dorte Møller Jensen3,9,10
Abstract
Background: Twins may be at increased risk of dysglycaemic disorders due to adverse fetal conditions. Data
from Africa regarding this association is limited. We studied impaired glucose tolerance (IGT) and other types of
dysglycemia among twins and singletons in Guinea-Bissau.
Methods: The study was conducted from February 2011 until March 2012 at the Bandim Health Project, a health
and demographic surveillance system site in the capital Bissau. Twins (n = 209) and singletons (n = 182) were
recruited from a previously established cohort. Oral glucose tolerance tests (OGTT) were performed, along with
anthropometrics and collection of clinical and dietary data.
Results: Median age was 16.6 and 14.2 years between twins and singletons, respectively (P = 0.08). Mean birth
weight was 2410 vs. 3090 g, respectively (P < 0.001). Twins had higher median fasting- and two hour capillary
plasma glucose, 5.4(3.2–8.2) vs. 5.0(3.2–11.5) mmol/L (P < 0.001) and 6.8(3.4–11.3) vs. 6.2(3.2–12.1) mmol/L (P < 0.001),
respectively, compared to singletons. The prevalence of IGT was 2.5 % (5/209) vs. 3.5 % (6/182) (RR = 0.73,
95 % CI: 0.20–2.64). 12 % (25/209) of twins had impaired fasting glucose (IFG), compared to 3.5 % (6/182) of
singletons (3.63, 1.53–8.62). Dysglycemia (IGT and/or IFG or overt diabetes) was found in 17 % (35/209) vs. 9 %
(16/182) (1.90, 1.08–3.37), respectively.
Conclusions: Twins had higher glucose levels in both the fasting and postprandial state. This may indicate a
detrimental effect of the twin fetal environment on glucose metabolism later in life, a result contrary to
Scandinavian register studies. The IGT burden was low in this young age group and the risk was similar in twins and
singletons.
Keywords: Twins, Fetal origins hypothesis, Impaired glucose tolerance, Impaired fasting glucose, Diabetes, Sub-Saharan
Africa, Low birth weight
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Background
According to the fetal origins hypothesis an adverse fetal
environment predisposes to cardiovascular and dysmeta-
bolic disorders later in life [1–3]. Birth weight is often
used as a marker of the intrauterine environment, and
studies show that low birth weight (LBW) is associated
with type 2 diabetes mellitus (DM) [4–6]. As twins are
frequently born with LBW, they may be at higher risk of
developing metabolic diseases related to glucose homeo-
stasis, compared to singletons [7]. Such an association
would be of great interest in Sub-Saharan Africa, where
twinning is common [8] and the DM prevalence is in-
creasing rapidly [9, 10].
Twinning and metabolic disorders have been investigated
in high income settings. Clinical studies from Denmark
showed that twins had a higher burden of insulin resistance
and abdominal obesity [7], while an Italian study observed
a higher rate of metabolic syndrome [11]. Another Danish
population based study showed an increased risk of type 2
DM in elderly Danish twins [12]. A large scale Danish
register study did, however, not find a higher DM bur-
den among twins [13], a finding replicated later in a
Swedish register study [14].
Yet, the above results may not be applicable to Sub-
Saharan Africa, where the fetal and post-natal environment
experienced by twins and singletons could be different.
Here, large populations are currently undergoing consider-
able transition in life style, i.e., to a more westernized cal-
orie dense nutrition [4]. Combined with a high incidence of
LBW among African children due to fetal undernutrition
[15], the dysmetabolic consequences of fetal programming
could be more common in Sub-Saharan Africa, as the mis-
match between fetal and adult nutritional environments
seem to be particularly harmful [4]. Furthermore, malaria
and HIV could have a detrimental effect on the intrauterine
environment [4, 16], and changes could also arise due
to genetic background [17] and seasonal variation food
intake [18].
Impaired glucose tolerance (IGT) is a pre-diabetic con-
dition, with many individuals developing DM over 5–10
years [19, 20]. In Africa, the prevalence of IGT has been
estimated to between 2 and 13 % in various studies
[10, 21–24], with the burden rapidly increasing in several
parts [9]. The main objective of the present investigation
was describing the prevalence of IGT in a well-defined
cohort of young twins and singletons in Guinea-Bissau,
and to determine whether twins were at a higher risk of
IGT [8].
Methods
Study population
The study was carried out at the Bandim Health Project
(BHP), a health and demographic surveillance system
(HDSS) site in Bissau, the capital of Guinea-Bissau. The
BHP is a member of the “International Network for the
Demographic Evaluation of Populations and Their Health
in Developing Countries” (INDEPTH) and follows a popu-
lation of 100,000 individuals. All are registered with an
ID-number, age, sex, ethnic group and socio-economic
characteristics. Information is available regarding early
childhood morbidity, nutrition and vaccination status.
Twin status is recorded as well, and the HDSS database is
updated through regular censuses. A diabetes notification
system has been implemented.
Guinea-Bissau is ranking among the poorest nations in
the world [25]. It has experienced substantial political
instability over the last decades, including civil war.
Selection
Our study took place from February 2011 until March
2012, including during the rainy season from May to
October. Participants were recruited from a large cohort,
designed to investigate the prevalence of DM and meta-
bolic syndrome among young twins and singletons [26].
Twins in the present sub-study were drawn by oppor-
tunity from the original cohort, i.e., a field assistant and
a laboratory technician would re-visit the houses in the
BHP study area in a random order, enrolling any of the
previously participating twins available. For every twin
enrolled, it was attempted to recruit a random singleton
control from the previous study with roughly the same
age. The number of singletons investigated was therefore
lower, as sometimes a singleton control with similar age
was not available for testing. Twins were enrolled during
the entire study period, while singletons only from
September 2011.
Interview
All field interviews were conducted in the local language
Portuguese Creole. Provided consent, a questionnaire
was used to obtain information regarding family history
of DM, alcohol consumption and smoking habits. Twin
status was confirmed. Participants were asked if they
suffered from a chronic disease and if so whether this
was DM, hypertension, cardiovascular disease or other.
We used a specific questionnaire concerning nutritional
habits. It had not been validated previously, but was de-
signed to cover the major types of food intake in Bissau.
Physical examination
A manual sphygmomanometer was used for the blood
pressure measurements (BP), with the person seated at
rest and wearing light clothing. Weight was recorded
using regularly calibrated standard bathroom scales, height
by metallic measuring tape, with the person barefooted.
Middle upper arm circumference (MUAC) was measured
by non-stretchable measuring tape (TALC, Herts, United
Kingdom). Waist circumference (WC) was measured at
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midpoint between the lower costal margin and the iliac
crest, hip circumference (HC) at the widest point in the
gluteal region.
A Harpenden Skinfold Caliper (Baty International, West
Sussex, United Kingdom) was applied for triceps, biceps,
subscapular and suprailiac skinfold measurements [27].
Body fat percentage (BF%) was computed for children and
adults using previously established equations [28].
Zygosity
Using data from the previous study, genetically established
zygosity was available for a subset of twins. Zygosity had
also previously been evaluated by physical similarity in
twin pairs, with 89 % correctness [26].
Oral glucose tolerance test (OGTT)
The OGTTs were performed after an overnight fast. The
interview and physical examination were primarily carried
out during the OGTTs. The majority of measurements
were done by a HemoCue Glucose 201+ apparatus
(HemoCue, Ängelholm, Sweden), which uses capillary
blood and then automatically converts the results to
plasma values. In 7 % of the twins and 21 % of the single-
tons an AccuChek Active apparatus (Roche Diagnostics,
Indiana, USA) was used, due to shortage of HemoCue cu-
vettes. The AccuCheck Active also makes an automatic
conversion to plasma values. The coefficients of variation
(CV) for the two apparatuses are approximately 2 and
5 %, respectively.
For the OGTTs, a standard 75-g glucose solution was
used in individuals with a weight above 43 kg, while for
individuals below 43 kg a weight-adjusted glucose solu-
tion was used (1.75 g glucose/kg), in accordance with
common procedures [29]. The standardized glucose con-
tainers were provided by Odense University Hospital,
Denmark. Glucose measurements were done in fasting
(zero hours), at one hour and at two hours.
Definitions
The results were classified according to World Health
Organization (WHO) 1998 criteria for glucose measure-
ments on capillary plasma [29]. This was done since the
most recent WHO report of 2006 did not include IGT
criteria based on capillary plasma, only stating that the
fasting values for venous and capillary plasma glucose
are identical, whereas non-fasting capillary plasma yield
higher glucose values as opposed to venous plasma.
Hence, using capillary plasma values, IGT was defined
as two hour glucose level of 8.9–12.1 mmol/L, DM as a
fasting glucose ≥ 7.0 mmol/L or a two hour glucose of
≥12.2 mmol/L. A fasting glucose between 6.1 and
6.9 mmol/L was defined as impaired fasting glucose
(IFG). Dysglycemia was defined as having any of IGT,
IFG or DM, or a combination. Young individuals were
defined as <16 years. Low birth weight (LBW) was birth
weight below 2500 g.
Statistics
Data were entered using dBase 5.0 software (dataBased
Inc, Vestal, NY, USA). Statistical analyses were performed
in STATA 11 (Stata Corporation, College Station, TX,
USA). A P < 0.05 was considered significant.
Only participants with full OGTT results were analysed.
The IGT burden was included as proportions, while me-
dian glucose levels for monozygotic (MZ) twins, dizygotic
(DZ) twins and singletons were also calculated. Compari-
son of categorical outcomes between twins and singletons
was done using Poission regression and expressed as
relative risks (RR) and P-value. Linear regression was
applied in case of comparison of continuous outcomes
and expressed as differences (Diff ) and P-value. In both
models, the intra-pair relationship among twins was
controlled for with the cluster function, using a unique
pair number. For non-normally distributed continuous
variables, the Wilcoxon rank-sum test was applied and
values expressed as medians.
BMI was only calculated for individuals above 16 years.
For those below, BMI z-scores were calculated, using
current CDC growth references.
In a multivariate Poisson regression analysis, we ad-
justed for age, sex and high waist-to-hip ratio (above 0.90
for males and 0.85 for females) as potential confounders.
Rainy season (May-October) was also added, in order to
control for any related differences in food intake during
this time of year.
As a secondary analysis, we furthermore restricted our
metabolic analyses to twins where a singleton control
with exact match (1:1) on date of birth was available.
Age was here very similar for twins and singletons, with
the only difference due to singletons on average being
included slightly later.
Results
Enrolment
The previous twin study interviewed 678 twins. Among
these, an OGTT was performed in 209 confirmed twins
(82 twin-pairs and 45 single twins), selected randomly
by opportunity. In the previous study, 513 singleton con-
trols had also been interviewed. Of these, an OGTT was
performed in 183 confirmed singletons of similar age as
the twins. However, one singleton lacked information on
his two hour glucose and was excluded. The present
study therefore included 182 singletons with OGTT re-
sults (Figs. 1 and 2).
Baseline characteristics
Demographic and clinical data are displayed in Table 1.
Twins tended to be slightly older than singletons, 16.6 years
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vs. 14.2 years (P = 0.08). The age range was 7–34 years for
twins and 7-32 years for singletons. Among the twins,
116 (55.5 %) were adults aged 16 years or more. For the
singletons, 82 (45.3 %) were adults. One singleton
lacked information on age.
The male sex distribution was the same for twins and
singletons, 46 % (97/209) vs. 47 % (86/182) (P = 0.87),
respectively. Median BMI was lower for adult twins
compared to singletons, 20.6 vs. 21.7 kg/m2 (P = 0.02),
respectively. For young twins vs. singletons, no statistically
significant difference was observed in BMI z-score
(P = 0.23). Median WHR was higher for twins, 0.83
vs. 0.80 (P = 0.03), as was median BF%, 12.1 % vs. 11.1 %
(P = 0.02).
Among 56 twins and 46 singletons for whom informa-
tion on birth weight was available, 52 % of the twins were
born with LBW, as opposed to 4 % among singletons
(14.4, 3.6–57.3). The mean birth weight was 2410 g for
twins and 3090 g for singletons (Diff = 680 g, 95 % CI:
500–860).
Interviewed twins in 
main study
N = 678
Not included in
OGTT study
N=469
Included twins in OGTT
study
N = 209
DM
N = 5
IGT*
N = 5
IFG*
N = 25
Normoglycaemia
N = 174
Fig. 1 Inclusion of twins in the OGTT study. *One twin had co-existing IGT and IFG and has in this flowchart been classified as an IGT case
Interviewed singletons 
in main study
N=513
Not included in
OGTT study
N=330
Lacked information 
on 2 hour glucose
N=1
Included singletons in
OGTT study
N = 182
DM
N = 4
IGT*
N = 6
IFG*
N = 6
Normoglycaemia
N = 166
Fig. 2 Inclusion of singletons in the OGTT study. *Two singletons had co-existing IGT and IFG and have in this flowchart been classified as
IGT cases
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Comparison with the previous study
When comparing the sampled OGTT twins with the previ-
ous twin study, the sex distribution was similar. The sam-
pled OGTT twins were, however, slightly older, 16.6 vs.
15.3 years. For singletons, the sex distribution was also the
same. The sampled OGTT singletons were, however, slightly
younger compared to the previous study, 14.2 vs. 15.8 years.
Metabolic outcomes
OGTT results are displayed in Table 2. Twins had higher
median fasting glucose than singletons, 5.4 vs. 5.0 mmol/L
(P < 0.001), respectively. After the OGTT, twins likewise
had higher median glucose level, i.e., 6.8 vs. 6.2 mmol/L at
two hours (P < 0.001). No difference was observed in glu-
cose levels at one hour (P = 0.50).
In total, 2.5 % (5/209) of twins and 3.5 % (6/182) of
singletons had IGT (RR = 0.73, 95%CI: 0.20–2.64) (P =
0.63). Twelve percent (25/209) of twins and 3.5 % (6/182)
of singletons had IFG (3.63, 1.53–8.62) (P = 0.004). One
twin and two singletons had concomitant IGT and IFG,
but these were included as IGT (not IFG) cases in the
statistical analysis. 2.4 % (5/209) of the twins and 2.2 %
Table 1 Demographic and clinical characteristics for twins and singletons where OGTT results were available
Twins
N = 209
Singletons
N = 182
RR or DIFF P
Demographics
Male sex; % 97/209 (46 %) 86/182 (47 %) 0.98 (0.79–1.22) 0.87
Age; years (T = 209, S = 181) 16.6 (7–34) 14.2 (7–32) 0.08
Children (<16 years); % 93/209 (44.5 %) 99/181 (54.7 %) 0.81 (0.64–1.03) 0.09
Adults (≥16 years): % 116/209 (55.5 %) 82/181 (45.3 %) 1.23 (0.98–1.54) 0.08
Ethnicity; %
Balanta 23/209 (11.0 %) 14/182 (7.7 %) 1.42 (0.70–2.90) 0.33
Fula 14/209 (6.7 %) 21/182 (11.5 %) 0.58 (0.29–1.18) 0.13
Pepel 67/209 (32.1 %) 71/182 (39.0 %) 0.82 (0.60–1.13) 0.23
Mandinka 19/209 (9.1 %) 13/182 (7.1 %) 1.27 (0.59–2.75) 0.54
Other 86/209 (41.1 %) 62/182 (34.1 %) 1.21 (0.90–1.62) 0.21
Clinical data
Chronic disease; % 12/209 (5.7 %) 8/178 (4.5 %) 1.28 (0.54–3.03) 0.58
Family history of DMd; % 15/183 (8.2 %) 8/176 (4.5 %) 1.80 (0.73–4.46) 0.16
Tobacco smoking; %a 5/116 (4.3 %) 4/80 (5.0 %) 0.86 (0.21–3.48) 0.84
Alcohol intake; %a 37/116 (31.9 %) 17/80 (21 %) 1.50 (0.89–2.53) 0.13
MUACe; mm (T = 209, S = 181) 236 (38–354) 222 (140–342) 0.43
BMI/BMI z-score
BMI; kg/m2 (T = 119, S = 85)b 20.6 (3.14) 21.7 (3.52) 0.02
BMI-z-score (T = 88, S = 96)c −1.32 (1.41) −1.09 (1.07) 0.23
WHRf (T = 208, S = 180) 0.83 (0.42–1.00) 0.80 (0.35–1.38) 0.03
BFg; % (T = 207, S = 179) 12.1 (2.3–32.7) 11.1 (1.8–30.2) 0.02
Systolic BPh; mmHg (T = 201, S = 181) 104 (13) 107 (14) 3.5 (0.5–6.4) 0.02
Diastolic BPi; mmHg (T = 201, S = 181) 62 (11) 68 (12) 5.8 (3.3–8.3) <0.001
Hypertensionb 4/116 (3.5 %) 18/82 (22.0 %) 0.16 (0.05–0.45) <0.001
Birth weight; g (T = 56, S = 46) 2410 (469) 3090 (397) 680 (500–860) <0.001
Low birth weight (<2500 g); % 29/56 (52 %) 2/46 (4 %) 14.4 (3.6–57.3) <0.001
Cells are n/N (%), mean (SD) or median (range). For continuous data, the total number of observations is listed as T for twins and S for singletons, as information
was not complete for all variables
aOnly adults were asked about smoking and alcohol habits
bOnly for adults
cOnly for young twins and singletons
dDiabetes Mellitus
eMiddle Upperarm Circumference
fWaist-to-hip ratio
gBody Fat Percentage
hSystolic blood pressure
iDiastolic blood pressure
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(4/182) of the singletons had DM, based the OGTT re-
sults alone (1.09, 0.30–3.98). In total, 17 % (35/209) of
twins and 9 % (16/182) of singletons had some type of
dysglycaemia (1.90, 1.08–3.37) (P = 0.03).
Multivariate analysis
In a multivariate analysis, we adjusted the comparison of
IGT, IFG, DM and dysglycaemia among twins vs. single-
tons for potential confounders such as age, sex, WHR and
season. We found little effect on the risk of IGT, where
the adjusted RR for twins was 0.64 (0.18–2.32). Regarding
the risk of IFG among twins, the association became
stronger after adjustment, i.e., the adjusted RR was 4.47
(1.78–11.2) (P < 0.001) (Table 2). For dysglycemia, the as-
sociation remained fairly stable (2.01, 1.12–3.61).
Effect of zygosity
From the previous study, genetically established zygosity
was available for 133 twins, including 22 MZ and 111
DZ. At fasting, median glucose was significantly lower for
MZ twins compared to DZ, 4.9 vs. 5.4 mmol/L (P = 0.003).
No difference was observed during the OGTTs at one
(P = 0.85) or two hours (P = 0.68) (Fig. 3).
Table 2 OGTT results for 209 twins and 182 singletons
Twins Singletons RR (crude)b P crude RR (adjusted)c P adj.
N = 209 N = 182 N = 388
Fasting glucose; mmol/La 5.4 (3.2–8.4) 5.0 (3.2–11.5) <0.001
1-hour glucose; mmol/La 7.1 (4.3–12.8) 7.0 (4.1–13.3) 0.50
2-hour glucose; mmol/La 6.8 (3.4–11.3) 6.2 (3.2–12.1) <0.001
IGTd 5/209 (2.5 %) 6/182 (3.5 %) 0.73 (0.20–2.64) 0.63 0.64 (0.18–2.32) 0.50
IFGe 25/209 (12 %) 6/182 (3.5 %) 3.63 (1.53–8.62) 0.004 4.47 (1.78–11.2) <0.001
DMf 5/209 (2.4 %) 4/182 (2.2 %) 1.09 (0.30–3.98) 0.90 1.24 (0.35–4.42) 0.35
Dysglycaemiag 35/209 (17 %) 16/182 (9 %) 1.90 (1.08–3.37) 0.03 2.01 (1.12–3.61) 0.02
N is the total number of individuals in the adjusted analysis
aGlucose levels expressed as medians as non-normally distributed. Diff. could not be calculated here
bNo adjustment
cAdjusted for age, sex, high WHR (>0.90 for males and 0.85 for females) and rainy season
dImpaired Glucose Tolerance
eImpaired Fasting Glucose
fDiabetes Mellitus
gThe test person has any of IGT, IFG or DM, or a combination
Fig. 3 Median glucose levels (mmol/L) in fasting and at one and two hours during OGTT for the subset of twins where zygosity status was
known. MZ twins (22/133), DZ twins (111/133), Singletons = 182/182. Interquartile ranges (25 and 75 % percentiles) are displayed. Note: This
figure represents a subset of the data, i.e., only those with available zygosity and is therefore not directly comparable to the median values
displayed in Table 2
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Nutrition
Nutritional intake based on the food questionnaire is
displayed in the Supplemental Material (S1). Several var-
iables differed for twins and singletons. Thus, twins were
less likely to eat fish, meat and potatoes, compared to
singletons (P < 0.05).
Matched analysis
Eighty-seven twins had a singleton control with exactly
the same date of birth. Among the 87 twins, the median
age at enrolment was 15.2 years, compared to 15.4 years
for the 87 singletons (P = 0.69). Median fasting glucose
was 5.4 mmol/L for twins vs. 5.1 mmol/L for singletons
(P = 0.009). At two hours OGTT, the median glucose
levels were 6.7 vs. 6.3 mmol/L (P = 0.08) in the two
groups, respectively. No difference was observed at one
hour (P = 0.31).
IGT, IFG and DM results comparing Hemocue vs.
AccuCheck apparatuses
Fifteen twins and 38 controls were tested with an Accu-
Chek Active apparatus. Out of these, one twin and one
control were diagnosed with IGT. 194 twins and 144
singleton controls were tested with the HemoCue Glucose
201+ apparatus, out of which 4 twins and 5 controls had
IGT. There was no difference in IGT prevalence between
twins and controls tested with the HemoCue (P = 0.43)
nor with the AccuCheck (P = 0.48).
Among the twins and singleton controls tested with
the AccuCheck none had IFG or DM, whereas 25 twins
vs. six controls had IFG (P < 0.001) and five twins vs. four
controls had DM (P = 0.91) when tested with the Hemo-
Cue. In total, 34 twins and 15 controls had dysglycaemia
when tested with the Hemocue (P = 0.06.), whereas only
one twin and one control had dysglycaemia when tested
with the AccuCheck (P = 0.48).
Discussion
Main findings
The IGT prevalence was low among young individuals
in Guinea-Bissau, and it did not differ significantly be-
tween twins and singletons in both the crude and ad-
justed analysis. Twins did, however, have a significantly
higher IFG burden, as well as a higher median glucose
levels both in fasting and at two hours after glucose
intake.
Strengths and weaknesses
To our knowledge, this is the first study specifically per-
forming OGTTs among twins in Sub-Saharan Africa.
The fact that it was carried out within a well-established
cohort likely improves data quality and ensures good
follow-up possibilities.
When performing OGTTs, there is considerable intra-
subject variability [19]. This affects the precision of our
estimates, though the effect would likely be the same for
twins and singletons. The majority of participants were
investigated using a HemoCue device. Yet, for a small
number an AccuCheck apparatus was used. This may have
affected comparisons slightly. However, a sub-analysis
examining twins and singletons tested with HemoCue and
AccuCheck separately did not change the result signifi-
cantly with regard to the prevalence of dysglycaemia.
For practical reasons, we conducted point of care testing
using capillary blood glucose. This could be considered a
limitation, since venous plasma glucose is the golden
standard of glucose measurement [30]. According to a
WHO report of 2006 capillary blood can, however, be
used in under-resourced settings [30]. The CV of the two
glucose measuring devices used of 2–5 % was considered
acceptable and was likely less than the intra-subject
variability.
The young age of the participants is also an important
limitation as the risk of developing DM, IFG and IGT
markedly increases with age. This was a consequence of
the age of the overall HDSS. In the context of DM and
age, it should be noted that many Type 1 DM patients
die at an early age in Guinea-Bissau due to the cost and
difficulties of insulin delivery.
Our main statistical analysis was not individually
matched on age, but simply compared proportions of
IGT in the two groups. However, in a sub-group analysis
with exact 1:1 match on date of birth, a similar trend in
glucose levels as in the overall sample was found.
Twins and singleton controls were not matched on sex
either. Gender differences related to behavior and
biology may affect glucose metabolism, particularly in
adolescents [31, 32]. Yet, the sex distribution was very
similar for twins and singletons, and inclusion of gen-
der in the adjusted model did not change the estimates
significantly.
Information regarding chronic diseases as well as fam-
ily history of diabetes was based on interviews alone
which likely makes the estimates more uncertain. Hence,
these parameters were not included in the regression
model. The increased attention on DM in Guinea-Bissau
is fairly new, and during the field work our impression
was that many participants at the time had little or no
knowledge of the disease.
Birth weight was only available for 26 % of the partici-
pants due to many being born outside the BHP area.
Birth weight was also often missing in the HDSS regis-
trations from the 1980s and 1990s, and birth weight
could therefore not be introduced in our regression
model. Birth weight is a marker of the fetal environment,
albeit only a crude one. Gestational age is a likely con-
founder, since twin pregnancies are known to have shorter
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gestation than singletons, often resulting in LBW [33].
Unfortunately, information regarding gestational age
was unavailable. Previously, we have found that 41 % of
twins in Guinea-Bissau were prematurely born (<37 weeks),
compared to 23 % of singletons [34].
We did not have data regarding insulin sensitivity or
beta cell function during the OGTTs. In the previous study,
no difference was found in fasting insulin or HOMA insu-
lin resistance between twins and singletons [26].
Finally, we did not have any data regarding maternal
nutrition during pregnancy. This was a limitation, since
factors such as maternal BMI and diet are likely of im-
portance in fetal programming [31, 35].
Consistency with previous findings
A number of investigations have assessed IGT in Africa,
though with highly varying estimates, including between
urban and rural areas. A study from neighboring Guinea-
Conakry observed an IGT prevalence of 13 % in a middle-
aged population [21]. A recent study from Kenya found a
quite similar IGT burden of 12 %, though in a consider-
ably younger population with mean age 38.6 years [22].
An older survey from Cameroon described an urban IGT
prevalence of 2 % [23]. The overall IGT prevalence for the
Africa region has been estimated to 7.3 % for adults [10].
In high income settings, IGT burdens of similar propor-
tions have been observed [36, 37].
We did not observe a higher IGT burden among twins
compared to singletons. This could suggest that LBW in
twins – as a marker of adverse fetal conditions - is not
strongly associated with IGT in our setting. In this con-
text, it is important to consider whether different mech-
anisms lead to the LBW in twins vs. singletons. Twins
could often be born with LBW due to preterm delivery
and spatial limitations in utero, rather than due to an ac-
tual adverse fetal environment [13].
Our previous study found a prevalence of metabolic
syndrome of 3.0 % for twins vs. 3.6 % of singletons in
the same cohort, supporting that twins are not at higher
risk of dysmetabolic disorders later in life. No difference
was found in mean HbA1c either. Yet, as in the present
investigation, higher fasting glucose and higher IFG
prevalence were found in twins [26]. Adjusting for po-
tential confounders such as age, sex, WHR and season
caused the association between twin status and IFG to
become even stronger.
Apart from the studies by our group, data on twinning
and dysglycaemic disorders in Sub-Saharan Africa are
not available, though investigations from high income
settings have examined the association. Several smaller
clinical studies have shown an association between twin
status and dysglycemia [7, 12]. A Danish study found
that MZ twins were particularly disadvantaged in terms
of glucose metabolism [38], as they may experience even
more adverse fetal conditions, e.g., due to placental vas-
cular anastomoses [39]. However, the findings of the
smaller clinical investigations have not been replicated
in large scale Scandinavian register studies [13, 14],
which found no differences in the DM burden between
twins and singletons in adulthood. Furthermore, a study
observed no intra-pair differences in glucose metabolism
among extremely birth weight discordant MZ twins,
indicating common genetic factors in the association
between LBW and adult metabolic disease [40].
Importantly, we do not know how these findings relate
to Guinea-Bissau, where twins have a very high perinatal
mortality of 22 % [34]. Infant twin mortality is also two-
fold elevated, compared to singletons [41]. Birth weight
below 2000 g thus remains an important risk factor for
death during the first year of life [41]. A recent study
demonstrated that twins were not hospitalized more
often in Guinea-Bissau during infancy, despite elevated
mortality [41]. A considerable “healthy survivor bias” is
therefore likely, favoring twins in adulthood.
Also, adverse exposures during fetal life could be mark-
edly different in Africa. Thus, in our setting around 13 %
of all children are born with LBW [26], with twins ac-
counting for 20–23 % of those [42]. This indicates that
sub-optimal nutrition during pregnancy is common in
Guinea-Bissau. Of particular concern in Africa is currently
the combination of a resource poor fetal environment,
followed by a nutrient rich diet later in life due to changes
in type of food intake and availability in the populations,
as this may predispose to DM and other metabolic disor-
ders [4]. Data regarding nutritional transition in relation
to DM are not available from Guinea-Bissau, but the ten-
dency would likely be similar. Moreover, malaria - which
is endemic across Africa - has been associated with both
reduced fetal growth and elevated post-natal blood pres-
sure [16], as has maternal HIV infection [43], access to
antenatal care and socio-economic factors [44]. Such
exposures could influence our glucose results, especially if
correlated to twin status. Interestingly, singletons had
higher blood pressure than twins.
In the subset of twins where zygosity status was known,
MZ twins did not have higher glucose levels than DZ
twins. This was somewhat surprising, as MZ twins in
theory should experience an even more adverse fetal
enviroment. A study from the main maternity ward in
Bissau found a MZ twinning rate of 3.4/1000 [34].
We collected basic information regarding the nutritional
intake. We found that singletons had a more frequent in-
take of fish, potatoes and meat. Twins had a more frequent
intake of deep fried and oily food on a weekly basis,
whereas singletons had a higher intake on a daily basis.
There was no difference in the intake of vegetables, sweets
and sweet beverages. Thus, dietary differences were present,
though we do not know to what extent this influenced the
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results (see Additional file 1). Therefore, though we ob-
served significantly higher fasting and postprandial glucose
levels for twins, we cannot ascertain whether this related
specifically to the fetal environment or maternal and post-
natal nutritional patterns.
In relation to the divergent IGT and IFG findings ob-
served, it is important to note that they may have a dif-
ferent etiology. IFG has been related to raised hepatic
glucose output and dysfunction in insulin secretion,
whereas IGT is associated with peripheral insulin resist-
ance [20]. Thus, it is possible that twins are at an in-
creased risk of IFG, but not IGT.
Finally, it has been proposed that age is important in
unmasking the effect of adverse exposures during fetal life
[12]. As our cohort was young, we cannot exclude that
over time regulatory deficits in twins - possibly expressed
early by higher fasting and two hour glucose levels - will
lead to an increased risk of IGT, and subsequently DM.
Perspectives
The burden of DM is rising rapidly in Africa, though
limited data are available about the underlying etiology
[45]. If fetal programming is an important component in
DM development, the causal pathways may indeed be
different in low income African settings [4]. Twin studies
represent a powerful tool in diabetes research, as they can
control for the contribution of genetic factors [14, 40]. It is
therefore relevant to conduct more metabolic twin studies
in Africa. Larger studies with older participants are en-
couraged, particularly those comparing birth weight dis-
cordant MZ twin pairs, as a means of evaluating the effect
of the intrauterine environment alone, without genetic
and post-natal environmental confounding [40].
Conclusions
Our OGTT-study conducted among twins and singletons
in Guinea-Bissau is the first of its kind in Africa, and it
provides unique insights into a high mortality population,
which has not been investigated before. We found higher
blood glucose levels among twins both in the fasting and
postprandial states, which could relate to the twin fetal en-
vironment. No significant difference was observed in IGT
prevalence between the two groups, and the overall bur-
den of dysglycemia was low.
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